Salmeterol/fluticasone combination inhaler. A new, effective and well tolerated treatment for asthma

Clinical Drug Investigation

Volumn 16, Issue 3, 1998, Pages 193-201

  Bateman, E D ^a   Britton, M ^b   Carrillo, J ^c   Almeida, J ^d   Wixon, C ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ST PETER S HOSPITAL   (United Kingdom)

^c Seccion de Algergia   (Spain)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; FLUTICASONE; HYDROCORTISONE; SALMETEROL; SALMETEROL PLUS FLUTICASONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DYSPHONIA; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HOARSENESS; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; INHALER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SYMPTOM; TACHYCARDIA;

EID: 0031718205     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199816030-00003     Document Type: Article

References (20)

1. British Thoracic Society. The British Guidelines on Asthma Management. Thorax 1997; 52 Suppl. 1: S1-S21
2. Global strategy for asthma management and prevention. WHO/NHLBI Workshop Report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659, 1995
3. Chervinsky P, van-As A, Bronsky EA, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. J Allergy Clin Immunol 1994; 94: 676-83
4. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group [see comments]. Thorax 1993; 48: 817-23
5. Noonan M, Chervinsky P, Busse WW, et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995; 152: 1467-73
6. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388-92
7. Juniper EF, Kline PA, Vanzieleghem MA, et al. Reduction of hudesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991; 87: 483-9
8. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344: 219-24
9. Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481-8
10. Ond PW, Dal Negro R, Colman NC, et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma I: Lung function and symptoms. Am J Respir Crit Care Med 1998; 157: A416
11. Ind PW, Dal Negro R, Colman NC, et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma II: Exacerbations. Am J Respir Crit Care Med 1998; 157: A415
12. Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and hudesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405-11
13. Boulet LP, Cowie R, Johnston P, et al. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. Canadian Study Group. J Asthma 1995; 32: 429-36
14. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992; 146: 1559-64
15. James PN, Anderson JB, Prior JG, et al. Patterns of drug taking in patients with chronic airflow obstruction. Postgrad Med J 1985; 61: 7-10
16. Kinsman RA, Dirks JF, Dahlem NW. Noncompliance to prescribed-as-needed (PRN) medication use in asthma: usage patterns and patient characteristics. J Psychosom Res 1980: 24: 97-101
17. Harding JM, Modell M. How patients manage asthma. J R Coll Gen Pract 1985; 35: 226-8
18. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 1986; 77: 65-70
19. Coutts JAP, Gibson NA, Palon JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992; 67: 332-3
20. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-4